NCT07109999

Biomarker-based Alzheimer's Disease Cohort Study (BASIC)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,835 (estimated)
• Sponsor: Xuanwu Hospital, Beijing · Academic / Other
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

This study adopts a prospective cohort design, constructing a single-center cohort by recruiting patients with Alzheimer's disease (AD) who are positive for AD biomarkers. First, the investigators aim to establish a cohort of AD patients with positive biomarkers, thereby reserving suitable patient resources for future AD-related clinical trials. Second, based on the established cohort, the investigators will explore the associations between AD-related biomarkers and clinical manifestations among the elderly population in China, and identify potential risk factors influencing the progression of AD. Third, according to the identified risk factors for AD progression, the investigators will construct a risk early warning model for the progression rate of AD based on biomarkers, in order to achieve early identification and precise prevention and control of the progression risk of AD.

Conditions

• Alzheimer Disease

Interventions

Type	Name	Description
OTHER	None-placebo	This study is an observational study, and no interventions will be implemented.

Timeline

• Start date: 2019-01-01
• Primary completion: 2050-12-31
• Completion: 2050-12-31
• First posted: 2025-08-07
• Last updated: 2025-08-07

Locations

1 site across 1 country: China